The Securities and Exchange Commission informed medical device company Misonix that it has concluded its investigation and does not intend to bring an enforcement action regarding potential violations of the Foreign Corrupt Practices Act.

Learn More
Already a member? Sign in to an existing account.

Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,...